HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)
Clinical trial NCT06210334 · UNKNOWN
Trial details
- NCT number
- NCT06210334
- Sponsor
- Li Xiao Wei
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2025-07-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.